Karin Tran Lundmark
31 – 40 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension : The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Extracellular retention of PDGF-B directs vascular remodeling in mouse hypoxia-induced pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
The extracellular matrix in early and advanced pulmonary arterial hypertension
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Midterm results of the Ross procedure in children : An appraisal of the subannular implantation with interrupted sutures technique
(
- Contribution to journal › Article
-
Mark
MicroRNA-Dependent Control of Serotonin-Induced Pulmonary Arterial Contraction
(
- Contribution to journal › Article
- 2016
-
Mark
Versican accumulates in vascular lesions in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2015
-
Mark
Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
(
- Contribution to journal › Article
-
Mark
Perlecan heparan sulfate is required for the inhibition of smooth muscle cell proliferation by all-trans-retinoic acid
(
- Contribution to journal › Article
- 2014
-
Mark
Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury
(
- Contribution to journal › Article
-
Mark
Perlecan Heparan Sulfate Proteoglycan Is a Critical Determinant of Angiogenesis in Response to Mouse Hind-Limb Ischemia
(
- Contribution to journal › Article